Saturday, January 29, 2022
HomeGeneralIndia's Bharat Biotech says its Covaxin booster dose offers long term protection

India’s Bharat Biotech says its Covaxin booster dose offers long term protection

January 8 (Reuters): India’s Bharat Biotech said on Saturday a booster dose of its COVID-19 vaccine Covaxin offered long-term protection from severe disease in a trial.

The company said a booster dose was given to trial participants six months after they received their second dose.


Disclaimer :- This story has not been edited by The Sen Times staff and is auto-generated from news agency feeds.
Source: Reuters


RELATED ARTICLES

Most Popular

%d bloggers like this: